The use of recombinant factor VIIa (rVIIa, Novoseven) in the management of surgery and acute bleeding episodes in patients with high responding factor VIII inhibitors

被引：0
|
作者：
机构：
来源：
Irish Journal of Medical Science | 2001年 / 170卷 / Suppl 2期
关键词：
Tranexamic Acid; Central Venous Access Device; Novoseven; Bone Marrow Trephine; FVIII Inhibitor;
D O I：
10.1007/BF03169824
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors
    O'Connell, N
    Mc Mahon, C
    Smith, J
    Khair, K
    Hann, I
    Liesner, R
    Smith, OP
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (03) : 632 - 635
  • [2] Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.
    O'Connell, N
    McMahon, C
    Smith, J
    Khair, K
    Hann, I
    Leisner, R
    Smith, O
    BLOOD, 2001, 98 (11) : 83B - 83B
  • [3] Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors
    Smith, OP
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 : 22 - 25
  • [4] NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia
    Franchini, Massimo
    Lippi, Giuseppe
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (06) : 733 - 740
  • [5] Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven®):: a single centre experience
    Habermann, B
    Hochmuth, K
    Hovy, L
    Scharrer, I
    Kurth, AHA
    HAEMOPHILIA, 2004, 10 (06) : 705 - 712
  • [6] Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors
    Key, NS
    Aledort, LM
    Beardsley, D
    Cooper, HA
    Davignon, G
    Ewenstein, BM
    Gilchrist, GS
    Gill, JC
    Glader, B
    Hoots, WK
    Kisker, CT
    Lusher, JM
    Rosenfield, CG
    Shapiro, AD
    Smith, H
    Taft, E
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (06) : 912 - 918
  • [7] Recombinant factor VIIa (NovoSeven(R)) in the treatment of internal bleeding in patients with factor VII and IX inhibitors
    Lusher, JM
    HAEMOSTASIS, 1996, 26 : 124 - 130
  • [8] Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery
    Chapman, Alistair J.
    Blount, Andrew L.
    Davis, Alan T.
    Hooker, Robert L.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 40 (06) : 1314 - 1319
  • [9] Consensus protocol for the use of recombinant Factor VIIa (NovoSeven™) in elective orthopedic surgery in hemophilic patients with inhibitors
    Giangrande, P.
    Wilde, J.
    Madan, B.
    Ludlam, C. A.
    Tuddenham, E. G. D.
    Goddard, N.
    Dolan, G.
    Ingerslev, J.
    HAEMOPHILIA, 2008, 14 (02) : 406 - 406
  • [10] Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VIII and IX inhibitors
    Barthels, M
    THROMBOSIS RESEARCH, 1999, 95 (04) : S31 - S38
12345